Nothing Special   »   [go: up one dir, main page]

GB9205917D0 - Pharmaceuticals - Google Patents

Pharmaceuticals

Info

Publication number
GB9205917D0
GB9205917D0 GB929205917A GB9205917A GB9205917D0 GB 9205917 D0 GB9205917 D0 GB 9205917D0 GB 929205917 A GB929205917 A GB 929205917A GB 9205917 A GB9205917 A GB 9205917A GB 9205917 D0 GB9205917 D0 GB 9205917D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceuticals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929205917A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB929205917A priority Critical patent/GB9205917D0/en
Publication of GB9205917D0 publication Critical patent/GB9205917D0/en
Priority to KR1019940703269A priority patent/KR950701638A/en
Priority to AU37607/93A priority patent/AU3760793A/en
Priority to JP5516084A priority patent/JPH07504666A/en
Priority to EP93906699A priority patent/EP0631583A1/en
Priority to PCT/GB1993/000560 priority patent/WO1993019075A1/en
Priority to CA002132303A priority patent/CA2132303A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB929205917A 1992-03-18 1992-03-18 Pharmaceuticals Pending GB9205917D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB929205917A GB9205917D0 (en) 1992-03-18 1992-03-18 Pharmaceuticals
KR1019940703269A KR950701638A (en) 1992-03-18 1993-03-18 Antiviral phosphonic acid derivatives of purine analogues
AU37607/93A AU3760793A (en) 1992-03-18 1993-03-18 Antiviral phosphonic acid derivatives of purine analogues
JP5516084A JPH07504666A (en) 1992-03-18 1993-03-18 Antiviral phosphonic acid derivatives of purine analogs
EP93906699A EP0631583A1 (en) 1992-03-18 1993-03-18 Antiviral phosphonic acid derivatives of purine analogues
PCT/GB1993/000560 WO1993019075A1 (en) 1992-03-18 1993-03-18 Antiviral phosphonic acid derivatives of purine analogues
CA002132303A CA2132303A1 (en) 1992-03-18 1993-03-18 Antiviral phosphonic acid derivatives of purine analogues

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929205917A GB9205917D0 (en) 1992-03-18 1992-03-18 Pharmaceuticals

Publications (1)

Publication Number Publication Date
GB9205917D0 true GB9205917D0 (en) 1992-04-29

Family

ID=10712396

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929205917A Pending GB9205917D0 (en) 1992-03-18 1992-03-18 Pharmaceuticals

Country Status (7)

Country Link
EP (1) EP0631583A1 (en)
JP (1) JPH07504666A (en)
KR (1) KR950701638A (en)
AU (1) AU3760793A (en)
CA (1) CA2132303A1 (en)
GB (1) GB9205917D0 (en)
WO (1) WO1993019075A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2485597C (en) 2002-05-13 2013-07-02 Metabasis Therapeutics, Inc. Process for preparation of cyclic prodrugs of pmea and pmpa
WO2004037161A2 (en) 2002-05-13 2004-05-06 Metabasis Therapeutics, Inc. Cyclic prodrugs of pmea one of its analogues
RU2006138907A (en) 2004-06-08 2008-07-20 Метабазис Терапеутикс SYNTHESIS OF COMPLEX CYCLIC ETHERS USING LEWIS ACID
ES2401285T3 (en) 2004-12-16 2013-04-18 The Regents Of The University Of California Drugs with lung as target
ES2874774T3 (en) 2011-12-22 2021-11-05 Geron Corp Guanine Analogs as Telomerase Substrates and Telomere Length Affects
CN103665043B (en) 2012-08-30 2017-11-10 江苏豪森药业集团有限公司 A kind of tenofovir prodrug and its application in medicine
SI2970346T1 (en) 2013-03-15 2018-12-31 The Regents Of The University Of California Acyclic nucleoside phosphonate diesters
AU2015217221A1 (en) 2014-02-13 2016-08-11 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
JP2017520545A (en) 2014-07-02 2017-07-27 リガンド・ファーマシューティカルズ・インコーポレイテッド Prodrug compounds and their use
JP6708329B2 (en) 2014-09-15 2020-06-10 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Nucleotide analogues
US10377782B2 (en) 2015-09-15 2019-08-13 The Regents Of The University Of California Nucleotide analogs
WO2019139919A1 (en) 2018-01-09 2019-07-18 Ligand Pharmaceuticals, Inc. Acetal compounds and therapeutic uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL160927B1 (en) * 1987-11-30 1993-05-31 Beecham Group Plc Method for manufacturing new derivatives of purine
EP0353955A3 (en) * 1988-08-02 1991-08-14 Beecham Group Plc Novel compounds
GB8912043D0 (en) * 1989-05-25 1989-07-12 Beecham Group Plc Novel compounds
ATE167679T1 (en) * 1990-09-14 1998-07-15 Acad Of Science Czech Republic PHOSPHONATE PRECURSORS

Also Published As

Publication number Publication date
WO1993019075A1 (en) 1993-09-30
JPH07504666A (en) 1995-05-25
AU3760793A (en) 1993-10-21
EP0631583A1 (en) 1995-01-04
CA2132303A1 (en) 1993-09-30
KR950701638A (en) 1995-04-28

Similar Documents

Publication Publication Date Title
AP9300494A0 (en) Pharmaceuticals
GB9221468D0 (en) Pharmaceuticals
GB9204565D0 (en) Pharmaceuticals
GB9219163D0 (en) Pharmaceuticals
GB9205917D0 (en) Pharmaceuticals
GB9214184D0 (en) Pharmaceuticals
GB9201961D0 (en) Pharmaceuticals
GB9220585D0 (en) Pharmaceuticals
GB9208321D0 (en) Pharmaceuticals
GB9205427D0 (en) Pharmaceuticals
GB9216906D0 (en) Pharmaceuticals
GB9205365D0 (en) Pharmaceuticals
GB9220508D0 (en) Pharmaceuticals
GB9205428D0 (en) Pharmaceuticals
GB9203977D0 (en) Pharmaceuticals
GB9205918D0 (en) Pharmaceuticals
GB9206075D0 (en) Pharmaceuticals
GB9207414D0 (en) Pharmaceuticals
GB9207820D0 (en) Pharmaceuticals
GB9202510D0 (en) Pharmaceuticals
GB9208434D0 (en) Pharmaceuticals
GB9211072D0 (en) Pharmaceuticals
GB9211082D0 (en) Pharmaceuticals
GB9211925D0 (en) Pharmaceuticals
GB9211926D0 (en) Pharmaceuticals